BACKGROUND/AIMS: Mutations in the acid-labile subunit (ALS) gene (IGFALS) have been associated with circulating insulin-like growth factor I (IGF-I) deficiency and short stature. Whether severe pubertal delay is also part of the phenotype remains controversial due to the small number of cases reported. We report 2 children with a history of growth failure due to novel IGFALS mutations. METHODS: The growth hormone receptor gene (GHR) and IGFALS were analyzed by direct sequencing. Ternary complex formation was studied by size exclusion chromatography. RESULTS: Two boys of 13.3 and 10.6 years, with pubertal stages 2 and 1, had mild short stature (-3.2 and -2.8 SDS, respectively) and a biochemical profile suggestive of growth hormone resistance. No defects were identified in the GHR. Patient 1 was homozygous for the IGFALS missense mutation P73L. Patient 2 was a compound heterozygote for the missense mutation L134Q and a novel GGC to AG substitution at position 546-548 (546-548delGGCinsAG). The latter causes a frameshift and the appearance of a premature stop codon. Size exclusion chromatography showed no peaks corresponding to ternary and binary complexes in either patient. CONCLUSION: Screening of the IGFALS is important in children with short stature associated with low serum IGF-I, IGFBP-3 and ALS. Copyright 2010 S. Karger AG, Basel.
BACKGROUND/AIMS: Mutations in the acid-labile subunit (ALS) gene (IGFALS) have been associated with circulating insulin-like growth factor I (IGF-I) deficiency and short stature. Whether severe pubertal delay is also part of the phenotype remains controversial due to the small number of cases reported. We report 2 children with a history of growth failure due to novel IGFALS mutations. METHODS: The growth hormone receptor gene (GHR) and IGFALS were analyzed by direct sequencing. Ternary complex formation was studied by size exclusion chromatography. RESULTS: Two boys of 13.3 and 10.6 years, with pubertal stages 2 and 1, had mild short stature (-3.2 and -2.8 SDS, respectively) and a biochemical profile suggestive of growth hormone resistance. No defects were identified in the GHR. Patient 1 was homozygous for the IGFALS missense mutation P73L. Patient 2 was a compound heterozygote for the missense mutation L134Q and a novel GGC to AG substitution at position 546-548 (546-548delGGCinsAG). The latter causes a frameshift and the appearance of a premature stop codon. Size exclusion chromatography showed no peaks corresponding to ternary and binary complexes in either patient. CONCLUSION: Screening of the IGFALS is important in children with short stature associated with low serum IGF-I, IGFBP-3 and ALS. Copyright 2010 S. Karger AG, Basel.
Authors: Eric M Kofoed; Vivian Hwa; Brian Little; Katie A Woods; Caroline K Buckway; Junko Tsubaki; Katherine L Pratt; Liliana Bezrodnik; Hector Jasper; Alejandro Tepper; Juan J Heinrich; Ron G Rosenfeld Journal: N Engl J Med Date: 2003-09-18 Impact factor: 91.245
Authors: Horacio M Domené; Alicia S Martínez; Jan Frystyk; Sonia V Bengolea; María G Ropelato; Paula A Scaglia; Jian-Wen Chen; Carsten Heuck; Ole D Wolthers; Juan J Heinrich; Héctor G Jasper Journal: Horm Res Date: 2007-01-10
Authors: Vivian Hwa; Cecilia Camacho-Hübner; Brian M Little; Alessia David; Lou A Metherell; Nesrin El-Khatib; Martin O Savage; Ron G Rosenfeld Journal: Horm Res Date: 2007-03-28
Authors: Martin O Savage; Vivian Hwa; Alessia David; Ron G Rosenfeld; Louise A Metherell Journal: Front Endocrinol (Lausanne) Date: 2011-12-12 Impact factor: 5.555